C4 Therapeutics, Inc. · NASDAQ:CCCC

Orbimed Advisors LLC's stake in C4 Therapeutics, Inc. fell to 1.00% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Orbimed Advisors LLC's stake in C4 Therapeutics, Inc. fell to 1.00%, 883,534 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
1.00%
Shares
883,534
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC0.50%521,368
OrbiMed Capital LLC1.00%883,534

Source

View original at SEC

Related